1295 related articles for article (PubMed ID: 12872524)
21. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
Okkels H; Sigsgaard T; Wolf H; Autrup H
Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
[TBL] [Abstract][Full Text] [Related]
22. Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer.
Singh M; Shah PP; Singh AP; Ruwali M; Mathur N; Pant MC; Parmar D
Mutat Res; 2008 Feb; 638(1-2):184-94. PubMed ID: 18035380
[TBL] [Abstract][Full Text] [Related]
23. [Interindividual differences in efficacy and toxicity induced by therapeutic drugs and xenobiotics in relation to genetic polymorphisms in xenobiotic metabolizing enzymes].
Ozawa S
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):69-81. PubMed ID: 10097514
[TBL] [Abstract][Full Text] [Related]
24. Genetic polymorphisms in CYP1A1, CYP1B1, COMT, GSTP1 and NAT2 genes and association with bladder cancer risk in a French cohort.
Fontana L; Delort L; Joumard L; Rabiau N; Bosviel R; Satih S; Guy L; Boiteux JP; Bignon YJ; Chamoux A; Bernard-Gallon DJ
Anticancer Res; 2009 May; 29(5):1631-5. PubMed ID: 19443378
[TBL] [Abstract][Full Text] [Related]
25. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility.
Rebbeck TR
Cancer Epidemiol Biomarkers Prev; 1997 Sep; 6(9):733-43. PubMed ID: 9298582
[TBL] [Abstract][Full Text] [Related]
26. [Role of gene polymorphisms of phase II of xenobiotic biotransformation from glutathione-S-transferase and N-acetyltransferase families in susceptibility to lung cancer among Mayak workers].
Rusinova GG; Azizova TV; Viazovskaia NS; Glazkova IV; Gur'ianov MIu; Osovets SV
Radiats Biol Radioecol; 2014; 54(4):350-9. PubMed ID: 25775823
[TBL] [Abstract][Full Text] [Related]
27. Influence of CYP2C9, GSTM1, GSTT1 and NAT2 genetic polymorphisms on DNA damage in workers occupationally exposed to organophosphate pesticides.
Singh S; Kumar V; Singh P; Banerjee BD; Rautela RS; Grover SS; Rawat DS; Pasha ST; Jain SK; Rai A
Mutat Res; 2012 Jan; 741(1-2):101-8. PubMed ID: 22108250
[TBL] [Abstract][Full Text] [Related]
28. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking.
Schneider J; Bernges U; Philipp M; Woitowitz HJ
Cancer Lett; 2004 May; 208(1):65-74. PubMed ID: 15105047
[TBL] [Abstract][Full Text] [Related]
29. Genetic polymorphism of xenobiotic metabolising enzymes, diet and cancer susceptibility.
Reszka E; Wasowicz W; Gromadzinska J
Br J Nutr; 2006 Oct; 96(4):609-19. PubMed ID: 17010218
[TBL] [Abstract][Full Text] [Related]
30. Head and neck squamous-cell cancer and its association with polymorphic enzymes of xenobiotic metabolism and repair.
Harth V; Schafer M; Abel J; Maintz L; Neuhaus T; Besuden M; Primke R; Wilkesmann A; Thier R; Vetter H; Ko YD; Bruning T; Bolt HM; Ickstadt K
J Toxicol Environ Health A; 2008; 71(13-14):887-97. PubMed ID: 18569591
[TBL] [Abstract][Full Text] [Related]
31. Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers.
Salagovic J; Kalina I; Stubna J; Habalová V; Hrivnák M; Valanský L; Kohút A; Biros E
Neoplasma; 1998; 45(5):312-7. PubMed ID: 9921921
[TBL] [Abstract][Full Text] [Related]
32. [Analysis of the polymorphic alleles of genes encoding phase 1 and phase 2 detoxication enzymes in patients with endometriosis].
Ivashchenko TE; Shved NIu; Kramareva NA; Aĭlamazian EK; Baranov VS
Genetika; 2003 Apr; 39(4):525-9. PubMed ID: 12760253
[TBL] [Abstract][Full Text] [Related]
33. Influence of GSTM1, GSTT1, GSTP1, NAT1, NAT2, EPHX1, MTR and MTHFR polymorphism on chromosomal aberration frequencies in human lymphocytes.
Skjelbred CF; Svendsen M; Haugan V; Eek AK; Clausen KO; Kure EH; Tuimala JT; Svendsen MV; Norppa H; Hansteen IL
Carcinogenesis; 2011 Mar; 32(3):399-405. PubMed ID: 21097530
[TBL] [Abstract][Full Text] [Related]
34. Biotransformation enzyme polymorphism and pesticide susceptibility.
Eaton DL
Neurotoxicology; 2000; 21(1-2):101-11. PubMed ID: 10794390
[TBL] [Abstract][Full Text] [Related]
35. A cross-sectional study of self-reported chemical-related sensitivity is associated with gene variants of drug-metabolizing enzymes.
Schnakenberg E; Fabig KR; Stanulla M; Strobl N; Lustig M; Fabig N; Schloot W
Environ Health; 2007 Feb; 6():6. PubMed ID: 17291352
[TBL] [Abstract][Full Text] [Related]
36. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms.
Hein DW; Doll MA; Fretland AJ; Leff MA; Webb SJ; Xiao GH; Devanaboyina US; Nangju NA; Feng Y
Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):29-42. PubMed ID: 10667461
[TBL] [Abstract][Full Text] [Related]
37. Genetic polymorphisms of CYP2E1, GST, and NAT2 enzymes are not associated with risk of breast cancer in a sample of Lebanese women.
Zgheib NK; Shamseddine AA; Geryess E; Tfayli A; Bazarbachi A; Salem Z; Shamseddine A; Taher A; El-Saghir NS
Mutat Res; 2013; 747-748():40-7. PubMed ID: 23628324
[TBL] [Abstract][Full Text] [Related]
38. [Genetic polymorphism in GST, NAT2, and MTRR and susceptibility to childhood acute leukemia].
Gra OA; Glotov AS; Kozhekbaeva Zhm; Makarova OV; Nasedkina TV
Mol Biol (Mosk); 2008; 42(2):214-25. PubMed ID: 18610829
[TBL] [Abstract][Full Text] [Related]
39. [Glutathione S-transferases genetic polymorphisms and human diseases: overview of epidemiological studies].
Habdous M; Siest G; Herbeth B; Vincent-Viry M; Visvikis S
Ann Biol Clin (Paris); 2004; 62(1):15-24. PubMed ID: 15047486
[TBL] [Abstract][Full Text] [Related]
40. Genetic polymorphisms of glutathione-S-transferase genes (GSTM1, GSTT1 and GSTP1) and upper aerodigestive tract cancer risk among smokers, tobacco chewers and alcoholics in an Indian population.
Soya SS; Vinod T; Reddy KS; Gopalakrishnan S; Adithan C
Eur J Cancer; 2007 Dec; 43(18):2698-706. PubMed ID: 17707637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]